These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18079321)

  • 1. Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer.
    Lyons LS; Rao S; Balkan W; Faysal J; Maiorino CA; Burnstein KL
    Mol Endocrinol; 2008 Mar; 22(3):597-608. PubMed ID: 18079321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.
    Lyons LS; Burnstein KL
    Mol Endocrinol; 2006 May; 20(5):1061-72. PubMed ID: 16384856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.
    Peacock SO; Fahrenholtz CD; Burnstein KL
    Mol Endocrinol; 2012 Dec; 26(12):1967-79. PubMed ID: 23023561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.
    Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S
    Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer.
    Rao S; Lyons LS; Fahrenholtz CD; Wu F; Farooq A; Balkan W; Burnstein KL
    Oncogene; 2012 Feb; 31(6):716-27. PubMed ID: 21765461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.
    Nomura T; Yamasaki M; Hirai K; Inoue T; Sato R; Matsuura K; Moriyama M; Sato F; Mimata H
    Mol Cancer; 2013 Apr; 12():27. PubMed ID: 23566222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth.
    Wu F; Peacock SO; Rao S; Lemmon SK; Burnstein KL
    J Biol Chem; 2013 Feb; 288(8):5463-74. PubMed ID: 23281476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells.
    Liu Y; Wu X; Dong Z; Lu S
    Int J Oncol; 2010 Mar; 36(3):623-33. PubMed ID: 20126983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav3-rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence.
    Lin KT; Gong J; Li CF; Jang TH; Chen WL; Chen HJ; Wang LH
    Cancer Res; 2012 Jun; 72(12):3000-9. PubMed ID: 22659453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer.
    Zhao N; Peacock SO; Lo CH; Heidman LM; Rice MA; Fahrenholtz CD; Greene AM; Magani F; Copello VA; Martinez MJ; Zhang Y; Daaka Y; Lynch CC; Burnstein KL
    Sci Transl Med; 2019 Jun; 11(498):. PubMed ID: 31243151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
    Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
    Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities.
    Magani F; Peacock SO; Rice MA; Martinez MJ; Greene AM; Magani PS; Lyles R; Weitz JR; Burnstein KL
    Mol Cancer Res; 2017 Nov; 15(11):1469-1480. PubMed ID: 28811363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer.
    Lee K; Liu Y; Mo JQ; Zhang J; Dong Z; Lu S
    BMC Cancer; 2008 Jun; 8():158. PubMed ID: 18518979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathways.
    Shah S; Hess-Wilson JK; Webb S; Daly H; Godoy-Tundidor S; Kim J; Boldison J; Daaka Y; Knudsen KE
    Mol Cancer Res; 2008 Sep; 6(9):1507-20. PubMed ID: 18819937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.
    Hunter SG; Zhuang G; Brantley-Sieders D; Swat W; Cowan CW; Chen J
    Mol Cell Biol; 2006 Jul; 26(13):4830-42. PubMed ID: 16782872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells.
    Citterio C; Menacho-Márquez M; García-Escudero R; Larive RM; Barreiro O; Sánchez-Madrid F; Paramio JM; Bustelo XR
    Sci Signal; 2012 Oct; 5(244):ra71. PubMed ID: 23033540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence.
    Libertini SJ; Tepper CG; Rodriguez V; Asmuth DM; Kung HJ; Mudryj M
    Cancer Res; 2007 Oct; 67(19):9001-5. PubMed ID: 17909000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.
    Titus MA; Zeithaml B; Kantor B; Li X; Haack K; Moore DT; Wilson EM; Mohler JL; Kafri T
    PLoS One; 2012; 7(1):e30192. PubMed ID: 22272301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
    Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
    Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.